Abstract
INTRODUCTION
Recent technological advances have increased the risk that de-identified brain images could be re-identified from face imagery. The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a leading source of publicly available de-identified brain imaging, who quickly acted to protect participants’ privacy.
METHODS
An independent expert committee evaluated 11 face-deidentification (“de-facing”) methods and selected four for formal testing.
RESULTS
Effects of de-facing on brain measurements were comparable across methods and sufficiently small to recommend de-facing in ADNI. The committee ultimately recommended mri_reface for advantages in reliability, and for some practical considerations. ADNI leadership approved the committee’s recommendation, beginning in ADNI4.
DISCUSSION
ADNI4 de-faces all applicable brain images before subsequent pre-processing, analyses, and public release. Trained analysts inspect de-faced images to confirm complete face removal and complete non-modification of brain. This paper details the history of the algorithm selection process and extensive validation, then describes the production workflows for de-facing in ADNI.
Highlights
ADNI is implementing “de-facing” of MRI and PET beginning in ADNI4.
“De-facing” alters face imagery in brain images to help protect privacy.
Four algorithms were extensively compared for ADNI and mri_reface was chosen.
Validation confirms mri_reface is robust and effective for ADNI sequences.
Validation confirms mri_reface negligibly affects ADNI brain measurements.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Christopher G. Schwarz,
Mark Choe,
Stephanie Rossi,
Sandhitsu R. Das,
Ranjit Ittyerah,
Evan Fletcher,
Pauline Maillard,
Baljeet Singh,
Danielle J. Harvey,
Ian B. Malone,
Lloyd Prosser,
Matthew L. Senjem,
Leonard C. Matoush,
Chadwick P. Ward,
Carl M. Prakaashana,
Susan M. Landau,
Robert A. Koeppe,
JiaQie Lee,
Charles DeCarli,
Michael W. Weiner,
Clifford R. Jack Jr.,
William J. Jagust,
Paul A. Yushkevich,
Duygu Tosun,
for the Alzheimer’s Disease Neuroimaging Initiative | October 11, 2024